In patients in Binet A/B stage, CD200 MFI < 189.5 could identify patients with relatively short TTT in CLL patients with mutated IGHV status, normal TP53 or CD38 < 30%. The gene discussed is CD38; the disease is B-cell chronic lymphocytic leukemia.